Type 2 Diabetes Mellitus in Obese Clinical Trial
Official title:
The Effect of Exenatide on Fasting Bile Acids in Newly Diagnosed Type 2 Diabetes Mellitus Patients, a Pilot Study
Newly diagnosed T2DM participants without hypoglycemic drugs intake were retrospective analyzed. Plasma total bile acids in fasting state (FTBAs) and other parameters were compared before and after exenatide treatment and correlation analysis between changes of FTBAs and glycemic parameters.
Newly diagnosed T2DM participants without hypoglycemic drugs intake were retrospective analyzed. Plasma total bile acids in fasting state (FTBAs) and other parameters were tested at baseline. Then exenatide were applied to the T2DM participants for 12 weeks. FTBAs and glycemic parameters were measured again after exenatide treatment, and correlation analysis between changes of FTBAs and glycemic parameters were conducted to investigate the role of BAs in the glycemic control effect of exenatide. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05606471 -
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
|
Phase 4 | |
Completed |
NCT05072990 -
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
|
||
Withdrawn |
NCT02977039 -
Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity
|
N/A | |
Recruiting |
NCT06223490 -
Effect of Cryolipolysis on Insulin Resistance
|
N/A | |
Completed |
NCT04363710 -
Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet
|
N/A | |
Recruiting |
NCT05277558 -
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
|
||
Recruiting |
NCT04621929 -
Obesity and Uric Acid Stones Study
|
Phase 3 | |
Completed |
NCT04332354 -
Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery
|
||
Completed |
NCT05890950 -
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
|
Phase 1 | |
Not yet recruiting |
NCT06442150 -
LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences
|
N/A | |
Withdrawn |
NCT04910997 -
Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes
|
N/A | |
Completed |
NCT04931836 -
The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults
|
N/A | |
Recruiting |
NCT06005012 -
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
|
Phase 2 | |
Completed |
NCT05409027 -
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
|
Phase 1 | |
Terminated |
NCT04741074 -
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
|
Phase 3 | |
Recruiting |
NCT05838287 -
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
|
Phase 4 | |
Active, not recruiting |
NCT04916314 -
REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05446415 -
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
|
N/A | |
Completed |
NCT05770076 -
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)
|
N/A | |
Completed |
NCT02937987 -
Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients
|